✦ LIBER ✦

Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study

✍ Scribed by Espiño-Lorenzo, Pilar; Manrique-Arija, Sara; Ureña, Inmaculada; Jiménez-Núñez, Francisco Gabriel; López-Lasanta, María; Romero-Barco, Carmen María; Belmonte-López, María Angeles; Irigoyen, María Victoria; Fernández-Nebro, Antonio

Book ID: 122147467
Publisher: Elsevier Science
Year: 2013
Tongue: Spanish
Weight: 239 KB
Volume: 9
Category: Article
ISSN: 2173-5743
DOI: 10.1016/j.reuma.2012.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline comorbidities in patients with

Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study

✍ Espiño-Lorenzo, Pilar; Manrique-Arija, Sara; Ureña, Inmaculada; Jiménez-Núñez, F 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 229 KB

Combination therapy with etanercept and

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor α agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)

Efficacy of tacrolimus in rheumatoid art

Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six-month, double-blind, randomized, dose-ranging study

✍ Daniel E. Furst; Kenneth Saag; M. Roy Fleischmann; Yvonne Sherrer; Joel A. Block 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Tight control is important in patients w

Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1

✍ Hiroshige Sano; Katsumitsu Arai; Takehiro Murai; Junichi Fujisawa; Naoki Kondo; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Influence of anti–tumor necrosis factor

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

✍ W. G. Dixon; K. D. Watson; M. Lunt; L. K. Mercer; British Society For Rheumatolo 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 111 KB 👁 2 views